FDA and avastin: Crossroads in an era of targeted therapies

Research output: Contribution to journal › Short survey › peer-review

ASJC Scopus subject areas

@article{6e22c6fcb21c403b8c69c8958911cfb0,

title = "FDA and avastin: Crossroads in an era of targeted therapies",

author = "Debu Tripathy",

year = "2010",

month = oct,

language = "English (US)",

volume = "24",

journal = "ONCOLOGY",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

number = "11",

}

TY - JOUR

T1 - FDA and avastin

T2 - Crossroads in an era of targeted therapies

AU - Tripathy, Debu

PY - 2010/10

Y1 - 2010/10

UR - http://www.scopus.com/inward/record.url?scp=78649657817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649657817&partnerID=8YFLogxK

M3 - Short survey

C2 - 21155445

AN - SCOPUS:78649657817

SN - 0890-9091

VL - 24

JO - ONCOLOGY

JF - ONCOLOGY

IS - 11

ER -